Postoperative C-reactive protein/albumin ratio is a biomarker of risk of recurrence and need for adjuvant chemotherapy for stage III colorectal cancer

Hiroya Matsuoka,Koji Ando,Qingjiang Hu,Yoko Zaitsu,Yasuo Tsuda,Yuichi Hisamatsu,Yuichiro Nakashima,Yasue Kimura,Eiji Oki,Masaki Mori
DOI: https://doi.org/10.1007/s10147-020-01672-3
2020-04-11
International Journal of Clinical Oncology
Abstract:Adjuvant chemotherapy is generally recommended for patients with stage III colorectal cancer. Even with adjuvant chemotherapy, 20–30% of such patients develop recurrences; the risk factors for recurrence are currently unclear. The preoperative systemic inflammation index has been linked to poor prognoses in patients with colorectal cancer; however, the relationship between postoperative systemic inflammation index and recurrence is unclear. We aimed to evaluate the association between preoperative and postoperative systemic inflammation indexes and recurrence in patients with stage III colorectal cancer.
oncology
What problem does this paper attempt to address?